Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ananda Pharma Plc AGM Information 2024

Jul 16, 2024

10286_sha_2024-07-16_e02e35f0-8c15-41d7-a4ea-9df62d399ad7.html

AGM Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4897W

Ananda Developments PLC

16 July 2024

16 July 2024

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

NOTICE OF ANNUAL GENERAL MEETING

Ananda announces that notice convening the Company's Annual General Meeting ("AGM") for 10.00am BST on 9 August 2024 at the offices of Shakespeare Martineau LLP, 6th Floor, 60 Gracechurch Street, London, EC3V, will be sent to shareholders in the Company today.

Full details of the resolutions proposed to the shareholders are available within the Notice of Meeting, available at https://anandadevelopments.com/publications/ under the Notices and Meetings tab. The Company further announces that Dr. Inbar Maymon Pomeranchik does not intend to seek re-election to the Board at the Company's AGM. Inbar will formally retire from the Board at the conclusion of the AGM to pursue other interests. The Chairman, Charles Morgan, said: "On behalf of the Board, I would like to thank Inbar for her commitment and contribution to the Company".

To allow shareholders to follow the proceedings of the AGM without attending in person, the Company will provide access online via the Investor Meet Company platform.

Shareholders are invited to submit questions for the board to consider. Questions can be pre submitted via the Investor Meet Company Platform up until 9am the day before the meeting and can be submitted at any time during the AGM itself.

Please note: shareholders will not be able to vote online and are requested to submit their votes via proxy as early as possible.

Shareholders that wish to attend the online AGM should register for the event in advance by using the following link:

https://www.investormeetcompany.com/ananda-developments-plc/register

Investors who already follow ANANDA DEVELOPMENTS PLC on the Investor Meet Company platform will automatically be invited.

To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:  

·      Investor Hub: investors.anandadevelopments.com

·      Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=       

·      LinkedIn : https://www.linkedin.com/company/anadevelopments/       

·      Twitter : https://twitter.com/AnandaPlc

·      Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor

-Ends-

For further information, please contact:

ANANDA DEVELOPMENTS PLC

Chief Executive Officer

Melissa Sturgess



Finance Director

Jeremy Sturgess-Smith
+44 (0)7463 686 497 [email protected]
Investor Hub

Engage with us directly at Ananda Developments' by signing up at: investors.anandadevelopments.com
SP ANGEL CORPORATE FINANCE LLP

Corporate Finance

Richard Morrison

Caroline Rowe
+44 (0)20 3470 0470
Corporate Broking

Abigail Wayne

Rob Rees
YELLOW JERSEY PR

Charles Goodwin

Zara McKinlay
+44 (0)20 3004 9512

The Directors of the Company accept responsibility for the contents of this announcement.

For more information, please visit:  investors.anandadevelopments.com/welcome

https://investors.anandadevelopments.com/link/Kyz4Qr

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXQKPBQFBKDQOD